2019 - 2020 LEGISLATURE
June 6, 2019 - Introduced by Representatives Sinicki, Crowley, Hebl, Milroy,
Ohnstad, Rodriguez, Shankland, Skowronski, Spreitzer, Subeck, C. Taylor
and Zamarripa, cosponsored by Senators Larson, Ringhand and Wirch.
Referred to Committee on Rules.
AJR53,1,1 1Relating to: designating June 2019 as Myasthenia Gravis Awareness Month.
AJR53,1,42 Whereas, myasthenia gravis (MG) is an autoimmune neuromuscular disease
3that causes chronic weakness, in which antibodies attack receptors in the body and
4prevent muscle contraction; and
AJR53,1,85 Whereas, MG frequently weakens muscles that control eye movement, facial
6expressions, and swallowing, and its symptoms may include blurred vision, speech
7impairment, difficulty chewing, shortness of breath, an unstable gait, and a
8weakened grip; and
AJR53,1,109 Whereas, a diagnosis of MG may be missed or delayed because it shares
10symptoms in common with many other disorders; and
AJR53,1,1411 Whereas, in some cases, MG symptoms can worsen to the point of disability,
12grave illness, or death, if there are gaps in or an absence of the several crucial health
13care treatments that can enable those who endure MG to lead productive, active lives
14of normal longevity; and
1Whereas, MG is found most commonly in adult women under 40 and men over
260, but is not specific to either gender or any particular ethnic background; and
AJR53,2,33 Whereas, MG is nonhereditary and noncontagious; and
AJR53,2,54 Whereas, 10 to 20 out of every 100,000 Americans are diagnosed with MG, and
5support groups exist in Wisconsin for those people; now, therefore, be it
AJR53,2,7 6Resolved by the assembly, the senate concurring, That June 2019 is
7hereby designated Myasthenia Gravis Awareness Month in Wisconsin.
AJR53,2,88 (End)